TWD 65.1
(-0.61%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 96.51 Million TWD | -27.92% |
2022 | 133.89 Million TWD | 1.39% |
2021 | 132.06 Million TWD | 18.31% |
2020 | 111.62 Million TWD | -46.5% |
2019 | 208.64 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 56.72 Million TWD | 0.0% |
2024 Q1 | 56.72 Million TWD | -41.23% |
2023 Q4 | 96.51 Million TWD | 0.0% |
2023 Q2 | 123.37 Million TWD | 0.0% |
2023 Q1 | 123.37 Million TWD | -7.86% |
2023 FY | 96.51 Million TWD | -27.92% |
2023 Q3 | 96.51 Million TWD | -21.77% |
2022 Q3 | 133.89 Million TWD | 0.0% |
2022 Q4 | 133.89 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 83.954% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 37.906% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -128.866% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 91.194% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 93.961% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 91.192% |
Center Laboratories, Inc. | 269.22 Million TWD | 64.151% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -27.335% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 58.749% |
InnoPharmax Inc. | 22.24 Million TWD | -333.912% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | 30.468% |
Excelsior Biopharma Inc. | 217.28 Million TWD | 55.581% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | 23.883% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -233.454% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 65.999% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | 16.608% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -858.06% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -72.502% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | 18.481% |